InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Browse the full record of transactions filed by O'Connor Daniel J., Chief Executive Officer. Insider active across 3 companies, notably ONCOSEC MEDICAL Inc. Cumulatively, 4 reports have been logged. Total volume traded: €35k. The latest transaction was disclosed on 1 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€9,18816,000 shares@ €0.5742100.0% of flow
Common Stock
SEC:0001136261-22-000249:0·
Ideal exit: 26 Feb 2023 (T+270)
042,005 shares0
Class A Common Stock
SEC:0001213900-22-011644:0·
€12,7123,172 shares@ €4.0076100.0% of flow
Common Stock
SEC:0001493152-21-010454·
€12,7123,172 shares@ €4.007650.0% of flow
Common Stock
SEC:0001493152-21-010454:0·
4 of 4 declarations
About O'Connor Daniel J.
Daniel J. O'Connor is the Chief Executive Officer and President of OncoSec Medical Inc., Larkspur Health Acquisition Corp., and Seelos Therapeutics, Inc. He is responsible for the strategic and operational direction of these companies, overseeing product development and research initiatives. With a strong background in the biopharmaceutical sector, he is committed to promoting innovation and developing treatments that meet patient needs.
